Company Overview - Kane Biotech Inc. is focused on developing innovative wound care treatments that target biofilms, which are significant contributors to antibiotic resistance in wounds [3] - The company's product, revyve™, is designed to address both biofilms and wound bacteria, aiming to improve healing outcomes [3] Event Participation - Dr. Robert Huizinga, the Interim CEO of Kane Biotech, will present at the Advanced Wound Care Summit USA from July 15-17, 2025, in Boston, MA [1][2] - The presentation will be accessible on Kane's website starting July 16, 2025 [2] Industry Context - The Advanced Wound Care Summit USA serves as a platform for industry stakeholders, including innovators, payers, regulators, and multinational leaders, to collaborate on advancing wound care therapies [2]